Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 11, 2008, Pages 1229-1235

  Mayer, Sebastian ^a   Zur Hausen, Axel ^a   Watermann, Dirk Otto ^a   Stamm, Stefan ^b   Jäger, Markus ^a   Gitsch, Gerald ^a   Stickeler, Elmar ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Lymph node metastasis; Primary breast cancer; Soluble CD44; Tumor size

Indexed keywords

CD44V ANTIGEN; CD44V6 ANTIGEN; HERMES ANTIGEN; SOLUBLE CD44 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; BREAST CANCER; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR VOLUME; UPREGULATION;

ANTIGENS, CD; ANTIGENS, CD44; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTMENOPAUSE; PREMENOPAUSE; REFERENCE VALUES;

EID: 53749085227     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0397-z     Document Type: Article

References (19)

1. J Cichy E Pure 2003 The liberation of CD44 J Cell Biol 161 5 839 843
2. M Fichter 1997 Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C Oncogene 14 23 2817 2824
3. K Friedrichs 1995 CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer Cancer Res 55 22 5424 5433
4. N Guriec 1996 CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma Clin Exp Metastasis 14 5 434 439
5. N Guriec 1997 CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas Breast Cancer Res Treat 44 3 261 268
6. M Kaufmann 1995 CD44 variant exon epitopes in primary breast cancer and length of survival Lancet 345 8950 615 619
7. T Kawano 2005 Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer Am J Otolaryngol 26 5 308 313
8. T Kawano 2005 Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer Acta Otolaryngol 125 4 392 397
9. C Lackner 1998 Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis Breast Cancer Res Treat 47 1 29 40
10. MS Lockhart 1999 Evaluation of soluble CD44 in patients with breast and colorectal carcinomas and non-Hodgkin's lymphoma Oncol Rep 6 5 1129 1133
11. S Martin 1997 Soluble CD44 splice variants in metastasizing human breast cancer Int J Cancer 74 4 443 445
12. S Molica 2001 Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression Cancer 92 4 713 719
13. N Niitsu K Iijima 2002 High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma Leuk Res 26 3 241 248
14. H Ponta L Sherman PA Herrlich 2003 CD44: from adhesion molecules to signalling regulators Nat Rev Mol Cell Biol 4 1 33 45
15. W Remmele KH Schicketanz 1993 Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS) Pathol Res Pract 189 8 862 866
16. M Sanchez Lockhart 2001 Splice variant expression of CD44 in patients with breast and ovarian cancer Oncol Rep 8 1 145 151
17. SM Sheen-Chen 1999 Evaluation of the prognostic value of serum soluble CD 44 in patients with breast cancer Cancer Invest 17 8 581 585
18. E Stickeler 2001 The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4 Embo J 20 14 3821 3830
19. C Tempfer 1996 Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer Eur J Cancer 32A 11 2023 2025